The Effect of an Exercise Program in Breast Cancer Patients With Joint Pain While Taking Aromatase Inhibitors.

Christiana Care Health Services logo

Christiana Care Health Services

Status

Completed

Conditions

Women With ER Positive Breast Cancer Taking (AI) w Joint Discomfort and Stiffness

Treatments

Other: Arm A Directed exercise program
Other: Observation

Study type

Interventional

Funder types

Other

Identifiers

NCT02057536
CCC# 34006

Details and patient eligibility

About

The objective of this study is to determine if patients taking aromatase inhibitors (AI), who are experiencing joint discomfort and stiffness, would have reduction in this discomfort and stiffness by participating in a directed exercise program. The overarching objective is to improve patient compliance with the medication and ultimately clinical outcome. In this pilot study, we will utilize a scientific approach for proof of concept employing both objective (inflammatory cytokine profiles and Physical Therapy (PT) measurements) and subjective (patient perception) methods to support an evidence based clinical plan. Patients will be divided into two cohorts. Group A will receive AI therapy with a directed exercise program. Group B will receive AI therapy without a directed exercise program. Data will be collected when both cohorts of patients enroll in the study, at the end of PT for Group A and, at the end of 8 weeks for Group B. At these time points, both groups will undergo a PT evaluation; have blood drawn for cytokine profiles; answer questions on an iPad that includes: the Pain Disability Index, the PHQ-4 (Psycological Health Questionaire depression scale, and pain level scale.

Enrollment

30 patients

Sex

Female

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

1. Women over age 40 with histological evidence of hormone receptor positive breast cancer.

2. Post- menopausal 3. Adjuvant AI therapy. 4. Significant joint discomfort/stiffness when attempting activities of daily living which began or significantly increased after initiation of AI therapy.

5. Currently not in an active directed exercise program (>60 minutes 2x/wk)

Exclusion criteria

1. Preexisting RA or fibromyalgia. 2. Systemic metastasis 3. ECOG performance status of greater than 2.

-

Trial design

30 participants in 2 patient groups

Arm A
Experimental group
Description:
8 week directed exercise program
Treatment:
Other: Arm A Directed exercise program
Arm B
Active Comparator group
Description:
No directed exercise other than patients normal level of activity
Treatment:
Other: Observation

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems